Over the past nine years, patients with spinal muscular atrophy have seen the number of FDA-approved treatment options for ...

Aurion Biotech, Inc. plans $100M IPO for corneal disease treatments, limited competition, Phase 1/2 trials underway with ...

Total of non-dilutive $740,000 received to date from $1,000,000 grant, based on the continued development of 3D-printed plant-based fish and ...

But in the final weeks of the Biden ... in its assessment that a "research-related origin of the COVID-19 pandemic is more likely" and notes in its statement that both scenarios - lab origin ...

ACLF clinical trials expected to initiate in 1Q253 clinical data readouts expected by year-end 2025 across the ACLF pipeline, including on-going UNVEIL-IT® Phase 2 trialData of on-going Phase 1b ...

“We are now focused on raising awareness for unbuzzd™ with a 360-degree marketing approach and expect the RTD formulation ... statements contained herein include, but are not limited to, statements ...

The ongoing debate between self-reliance and imports in India’s defence sector is often riddled with misinformation and ...

Unlike short-lived fixes that merely accelerate metabolism for temporary effect, Lipozem takes a root-cause approach, ...

But in the final weeks of the Biden ... in its assessment that a "research-related origin of the COVID-19 pandemic is more likely" and notes in its statement that both scenarios - lab origin ...

And they would formulate a research hypothesis: “Immigrants do take jobs away ... but this reflects a misunderstanding of ...